143 related articles for article (PubMed ID: 6331040)
1. Foetal exposure to low doses of cyproterone acetate in the rat leads to functional endocrine abnormalities despite normal sexual morphogenesis.
Gómez F; Monnier B; Lemarchand-Béraud T
Acta Endocrinol (Copenh); 1984 Jul; 106(3):411-9. PubMed ID: 6331040
[TBL] [Abstract][Full Text] [Related]
2. Modifications of the gonadal function in the adult rat after fetal exposure to spironolactone.
Jaussan V; Lemarchand-Béraud T; Gómez F
Biol Reprod; 1985 Jun; 32(5):1051-61. PubMed ID: 3926011
[TBL] [Abstract][Full Text] [Related]
3. Morphofunctional study of the effects of fetal exposure to cyproterone acetate on the hypothalamo-pituitary-gonadal axis of adult rats.
Rossi GL; Bestetti GE; Reymond MJ; Lemarchand-Béraud T
Exp Brain Res; 1991; 83(2):349-56. PubMed ID: 1673659
[TBL] [Abstract][Full Text] [Related]
4. Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.
Knuth UA; Hano R; Nieschlag E
J Clin Endocrinol Metab; 1984 Nov; 59(5):963-9. PubMed ID: 6237116
[TBL] [Abstract][Full Text] [Related]
5. Sexual maturation in male mice treated with cyproterone acetate from birth to puberty.
Jean-Faucher C; Berger M; De Turckheim M; Veyssiere G; Jean C
J Endocrinol; 1984 Jul; 102(1):103-7. PubMed ID: 6234374
[TBL] [Abstract][Full Text] [Related]
6. The different mechanisms for suppression of pituitary and testicular function.
Sandow J; Engelbart K; von Rechenberg W
Med Biol; 1986; 63(5-6):192-200. PubMed ID: 3010006
[TBL] [Abstract][Full Text] [Related]
7. The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders.
Jeffcoate WJ; Matthews RW; Edwards CR; Field LH; Besser GM
Clin Endocrinol (Oxf); 1980 Aug; 13(2):189-95. PubMed ID: 6777092
[TBL] [Abstract][Full Text] [Related]
8. Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.
Rost A; Schmidt-Gollwitzer M; Hantelmann W; Brosig W
Prostate; 1981; 2(3):315-22. PubMed ID: 6458025
[TBL] [Abstract][Full Text] [Related]
9. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U
J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
[TBL] [Abstract][Full Text] [Related]
10. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Lamberts SW; Uitterlinden P; de Jong FH
Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic ethanol diet on pituitary-testicular function of the rat.
Salonen I; Huhtaniemi I
Biol Reprod; 1990 Jan; 42(1):55-62. PubMed ID: 2155675
[TBL] [Abstract][Full Text] [Related]
12. In vivo studies on the antiandrogenic effects of cimetidine versus cyproterone acetate in rats.
Baba S; Paul HJ; Pollow K; Janetschek G; Jacobi GH
Prostate; 1981; 2(2):163-74. PubMed ID: 6458024
[TBL] [Abstract][Full Text] [Related]
13. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
14. Effects of low doses of cyproterone acetate on sperm morphology and some other parameters of reproduction in normal men.
Fredricsson B; Carlström K
Andrologia; 1981; 13(4):369-75. PubMed ID: 6456681
[TBL] [Abstract][Full Text] [Related]
15. Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects.
Huhtaniemi I; Parvinen M; Venho P; Rannikko S
Int J Androl; 1991 Oct; 14(5):374-86. PubMed ID: 1839022
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyproterone acetate on the reproductive tract and pituitary-gonadal axis of the golden hamster.
Balbontin JB; Ferrario M
Andrologia; 1993; 25(5):289-92. PubMed ID: 8250293
[TBL] [Abstract][Full Text] [Related]
17. Effect of pulsatile gonadotropin-releasing hormone on the release of luteinizing hormone and follicle-stimulating hormone in vitro by anterior pituitaries from lactating and cycling rats.
Smith MS
Endocrinology; 1982 Mar; 110(3):882-91. PubMed ID: 6799281
[TBL] [Abstract][Full Text] [Related]
18. [Clinical use of antiandrogens in the female].
Moltz L; Schwartz U; Hammerstein J
Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
[TBL] [Abstract][Full Text] [Related]
19. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
20. [The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate].
Kocijancic A; Pfeifer M; Prezelj J; Meden-Vrtovec H; Vrhovec I
Jugosl Ginekol Opstet; 1982; 22(1-2):16-9. PubMed ID: 6215543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
